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Eight antifreeze-like peptides were produced by cleavage from engineered chimeric proteins. One was homologous to an antifreeze peptide of the 
winter flounder; the others differed in length and/or sequence. The homologous peptide and all those of equal or greater length were able to inhibit 
recrystallization. The longer peptides were so hydrophobic that their identification required modification of the usual protocols for high pressure 
liquid chromatography. Their elution positions were correlated to their hydrophobicities and their lengths. Additional naturally occurring 
antifreezes may be identifiable with this knowledge. 
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1. INTRODUCTION 
Certain fish [l-3] and terrestrial arthropods [4] con- 
tain ‘antifreeze’ proteins that cause non-colligative de- 
pression of their body fluids’ freezing point. The anti- 
freeze proteins are generally induced by low tempera- 
tures and they constitute a significant adaptation to cold 
environments. The winter flounder [4] and Alaskan 
plaice [l] have antifreeze peptides in which an 1 l-amino 
acid unit (TA??A6?) is repeated in tandem. Multiple 
species of such peptides are present. In winter flounder, 
the predominant species contain three TA??A,? repeats 
[5,6]. Less abundant peptide species may contain four 
[7,8] and five [9] repeats. Purification of the less abun- 
dant peptides has been problematic; their sequences are 
inferred from cDNA clones. 
The peptides Afa2, Afa3, Afa4, Afa5 and Afa6 form 
a homologous series containing two, three, four, five 
and six TA??A6? repeats, respectively. Peptides Afa3sB 
and Afa3, differ from Afa3 by the presence of a salt 
bridge, or by the presence of a carboxy-terminal a&i- 
&e, respectively; Afa3sm combines both types of differ- 
ence. The properties of the various peptides are summa- 
rized in Table I. Relative to antifreeze species that occur 
naturally in winter flounder, Afa3sr,,, is identical in se- 
quence to one of the major species, and Afa4 and Afa5 
are similar to probable minor species. However, the 
carboxy-terminal arginine residues of the analogues are 
unmodified, whereas the carboxy-termini of antifreeze 
peptides are amidated in the fish. 
What function might be served by the multiplicity of 
antifreeze peptides? To address this, we have attempted 
to differentiate between the properties of antifreeze pep- 
tides of varying length and composition, A series of 
antifreeze analogue (Afa) sequences was designed and 
generated using synthetic DNA. Chimeric proteins, 
consisting of Afa peptides joined to staphylococcal pro- 
tein A (Spa), were first produced in and purified from 
E. coli [lo]. This paper describes the separation of the 
peptides from their Spa fusion partners, and reports the 
activities of the various peptides in inhibiting the recrys- 
tallization of ice [l l-131. We also correlate their chro- 
matographic properties with properties predictable 
from their sequences. 
2. MATERIALS AND METHODS 
2.1. Treatment of chimeric proteins with cyanogen bromide 
The method derives from that of Gross [14]. Each reaction con- 
tained cyanogen bromide at 7 mg/ml, protein at 9.5 mg/ml, and 0.1 
M HCl. After 16 h incubation at 24’C, reaction mixtures were evapo- 
rated to dryness under vacuum. The products were redissolved in 50 
mM Tris-HCI (pH 7.5) to a final protein concentration of 47.5 mg/ml. 
Examination of the reaction products by SDS-PAGE showed that 
between 50 and 75% of the chimeric protein was cleaved. 
2.2. Filtration ofpeptides 
Solutions were passed through Centricon 10 filters (Amicon-W.R. 
Grace, Danvers, MA) to remove proteins larger than approximately 
10 kDa. Peptides present in the filtrates were subsequently concen- 
trated by retention on Centricon 3 filters. 
2.3. Calculation of hydropathy 
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We calculated the mean hydropathic index of all residues in a 
peptide, using standard values [15]. However, in peptides where the 
carboxy-terminal residue was non-polar (in all such cases, alanine), we 
adjusted the value of that residue’s hydropathy to -3.5 (the same as 
that for aspartic and glutamic acid residues) to reflect its content of 
a hydrophilic carboxyl group. We were aware that this adjustment 
would improve the correlation between hydropathic index and elution 
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position. No adjustments were made for amino-terminal residues be- 
cause aspartic acid, the amino-terminal residue of every peptide, is 
already assigned a hydropathy reflective of hydrophilic residues. 
Table I 
Predicted properties of antifreeze peptides 
2.4. High pressure liquid chromatography (HPLC) 
Chromatography was performed on reverse-phase Cu and C4 col- 
umns, using continuous buffer gradients. The eluent was monitored 
by simultaneously recording absorbance at 216 nm and 280 nm. Ini- 
tially, acetonitrile was utilized as the organic eluent (the buffer system 
varying from 84.9% water, 15% acetonitrile, 0.1% trifluoroacetic acid 
at loading to 10% water, 89.9% acetonitrile, 0.1% trifluoroacetic acid 
at the end of elution). After difficulties described in section 3, we then 
utilized only C, columns and a 2: 1 mixture of propan-2-01 and acetoni- 
trile (‘2I:A’) as the organic eluent (the buffer system varying from 
74.9% water, 25% 2I:A and 0.1% trifluoroacetic acid at loading to 
99.9% 21:A and 0.1% trifluoroacetic acid at elution). All results pre- 
sented were obtained with the latter system. We express elution char- 
acteristics in terms of the proportion of organic solvents present at the 
time of elution (they therefore fall between 25% and 99.9%). Solvents 
were HPLC grade, obtained from J.T. Baker Chemical Co., Phil- 
ipsburg, NJ. Trifluoroacetic acid (Sequanal Grade) was obtained from 
Pierce Chemical Co., Rockford, IL. 
Peptide Repeat Salt Arg” Length’ MP Adjusted 
units* bridge” residuei’ hydropa- 
thyC 
Afa2 
Afa3 
Afa3R 
Afa3sa 
Afa3sBm 
Afa4 
Afa5 
Afa6 
26 2,145 0.613 
37 3,042 0.851 
+ 31 3,127 0.824 
+ 31 3,143 0.554 
+ + 37 3,228 0.527 
48 3,939 0.948 
59 4,836 1.008 
70 5,133 1.050 
*Number of 1 l-residue consensus repeats in peptide. 
“The presence of a salt bridge is denoted by a plus (+) sign. 
bThe presence of a C-terminal arginine residue is denoted by a plus 
(+) sign. 
’ Length in aminoacyl residues. 
d Molecular mass. 
‘Adjusted hydropathic index for entire peptide molecule. 
2.5. Estimation of protein and peptide concentrations 
Concentrations were estimated by measuring the areas below A2,6 
peaks observed on the chart recorder and comparing these to the peak 
areas produced by eluting known quantities of pure proteins under 
identical conditions. Azso readings were not utilized because the anti- 
freeze peptides lack aromatic residues and absorb poorly at 280 nm. 
2.6. Amino acid analysis a@ protein sequencing 
Amino acid analysis of peptide Afa4 was carried out by the UCD 
Protein Structure Laboratory (Davis, CA). After hydrolysis of the 
peptide in 6 M hydrochloric acid, amino acids were separated by 
ion-exchange chromatography and quantitated by a ninhydrin detec- 
tion system. 
Sequencing of the amino-terminus of peptide Afa4 was performed 
by the Biomolecular Resource Center at UCSF (San Francisco, CA). 
Samples were subjected to Edman degradation using an Applied Bio- 
systems (Foster City, CA) 470A gas-phase sequencer. The PTH deriv- 
atives were identified and quantitated by reverse-phase HPLC using 
an on-line Applied Biosystems 120A PTH analyzer. 
could only find the free peptides Afa3sB and Afa3sa, as 
novel peaks. Most of the other peptides would be rela- 
tively more hydrophobic than Afa3,, and Afa3,,,, so 
we reasoned that the buffer system might have failed to 
elute them. Therefore we changed the organic eluent to 
a 2:l mixture of isopropanol and acetonitrile (‘2I:A’). 
Spa-Afa chimeric proteins were subjected to HPLC 
with the 21:A buffer system to determine their elution 
positions, which are reported by stippled bars in Fig. 1. 
The Spa-X protein, which has a sequence similar to that 
expected of a free Spa domain [lo], was also analyzed. 
This enabled us to understand, in subsequent work, 
which peaks were due to uncleaved chimeric proteins 
and free Spa domains. 
2.7. Assays of recrystallization-inhibiting activity 
Activity levels were estimated by observing the recrystallization of 
‘splat cooled’ samples [16] from a 2-fold dilution series of each prepa- 
ration, as described [lo]. 
3. RESULTS 
Ala6 
Ala5 
Af&4 
3.1. Identzjication of antifreeze peptides by HPLC 
To liberate antifreeze (Afa) peptides from chimeric 
Spa-Afa proteins [lo], we treated the latter with cyano- 
gen bromide (CNBr). The liberated Afa peptides should 
range in size and sequence: their characteristics are 
compared in Table I. CNBr treatment cleaves preferen- 
tially at peptide bonds carboxy-terminal to Met residues 
[ 141, and each chimeric protein contained a single inter- 
nal Met residue immediately amino-terminal to its anti- 
freeze moiety. Therefore, CNBr cleavage was expected 
to liberate intact Spa and Afa domains. We attempted 
to identify the free Spa and Afa domains by performing 
HPLC on the CNBr-treated samples. 
Ala3 so 
Afa3 R 
Ala3 
:::::::::::::~:::::::::g::::::::::::::::::::::: 
Afa2 m 
Spa-X 
i:i:l:l:i:i:I:I:i:i:i:i:i:i:i:i:i:i: 
. . . . II2 
4 -I 
25 30 35 40 45 50 55 60 65 70 
Elution position (% organic solvents) 
Fig. 1. The HPLC elution positions of peptides, denoted by the right 
end of each filled bar. The cognate chimeric protein’s elution position 
is denoted by the right end of each adjacent stippled bar. Spa-X is 
similar to the Spa portion of the chimeric proteins; its elution position 
When utilizing acetonitrile as the organic eluent, we is also shown. 
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CNBr-treated preparations were now subjected to 
HPLC utilizing the 21:A buffer system. Novel peaks 
were observed in the AZ16 spectra of samples corre- 
sponding to Afa2, Afa3s,, Afa3,,,, Afa4, Afa5 and 
Afa6. The new peaks (unlike those due to free Spa and 
the Spa-Afa proteins) had no counterparts in the A,,, 
spectra. This was to be expected for Afa peptides, since 
they contain no aromatic residues. 
The above analysis still did not identify novel peaks 
attributable to Afa3 and Afa3k. We suspected that Afa3 
and Afa3R might co-elute with other proteins. There- 
fore, the CNBr-treated samples were filtered to remove 
proteins larger than 10 kDa before HPLC. Filtration of 
the Afa3,, sample, as a positive control, demonstrated 
that the filtrate was depleted for other proteins but still 
contained free Afa3,,. The filtered preparations of 
Afa3 and Afa3, were now observed to give A2,6 peaks 
without AZ8,, counterparts, at elution positions previ- 
ously obscured by their corresponding chimeric pro- 
teins: we inferred that these peaks represented the free 
peptides. The elution positions of all the putative free 
Afa peptides are reported as solid bars in Fig. 1. 
3.2. Purification of antifreeze peptides 
Peptides Afa4, Afa5, and Afa6 were purified simply 
by collecting the appropriate fractions from HPLC elu- 
tions. However, the CNBr reaction mixtures containing 
Afa3, Afa3R, Afa3s,, Afa3sm, and Afa2, were first 
passed through low molecular weight cut-off filters. 
Part of each filtrate was analyzed by SDS-PAGE to 
confirm the absence of the larger proteins, and the re- 
mainder was subjected to HPLC with collection of the 
peak containing the peptide. 
Samples of the purified peptides were subjected to 
HPLC again to check purity and obtain a quantitative 
estimation of their concentrations. The set of AZ16 elu- 
tion spectra is shown in Fig. 2. In addition, we subjected 
Afa4 to two further analyses to test its identity: analysis 
of amino acid content, and amino-terminal sequencing. 
Afa4 was selected as the best single representative be- 
cause its size and its elution position fall in the middle 
of the range of the eight antifreeze peptides. The mea- 
sured and predicted amino acid contents of Afa4 are 
given in Table II. The correspondence between pre- 
dicted and measured values was good, and the unusual 
composition of Afa4 (particularly its high content of 
Ala) makes such a correspondence very unlikely to 
occur by chance. Five rounds of amino-terminal se- 
quencing of the Afa4 preparation inferred the sequence 
DTASD, in perfect correspondence with prediction. 
These analyses strongly suggest hat Afa4 is the major 
component in the Afa4 preparation, and thus lend cre- 
dence to the assignment of the other HPLC peaks to free 
antifreeze peptides. 
The activities of the different antifreeze peptides were 
compared. Because of the limited quantities available, 
we tested for the inhibition of ice recrystallization, an 
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Fig. 2. The A2,6 elution spectra of the purified Afa peptides. Baselines 
increase linearly because of absorbance by acetonitrile at 216 nm. 
Approximately 6 pg of peptide was loaded for each chromatography 
run. 
Table II 
Amino acid analysis of presumptive Afa4 peptide 
Amino acid Mole 8 
Measured Predicted 
Ala 67.1 70.8 
Arg 0.3 0.0 
Asx 10.8 10.4 
GYs 0.0 0.0 
Glx 0.9 0.0 
Gly 0.4 0.0 
His 0.1 0.0 
Ile 0.3 0.0 
Leu 6.7 6.2 
Lys 0.5 0.0 
Met 0.1 0.0 
Phe 0.0 0.0 
Pro 0.2 0.0 
Ser 2.2 2.1 
Thr 9.5 10.4 
Tyr 0.0 0.0 
Val 1.0 0.0 
Trp was not measured; Asp and Asn were measured together and are 
reported as Asx; likewise, Glu and Gln were measured together and 
are reported as Glx. The predicted sequence of Afa4 is DTAS- 
DAAAAAALTAANAAAAAALTAANAAAAAALTAANAAAA- 
AAATAA. 
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activity displayed by antifreeze proteins at lower con- 
centrations than those required for measurement of 
freezing point depression [16]. A titration scheme was 
employed [lo]: a 2-fold dilution series of each peptide 
was assayed for recrystallization inhibition, in order to 
define the minimum inhibitory concentration (mic) of 
each. The highest concentrations tested were 96 pg/ml. 
Table III reports the range of mic values obtained for 
each peptide over three separate xperiments. The vari- 
ability precludes precise quantitative comparisons. 
However, it is apparent hat Afa2 lacks activity and that 
all the other peptides are active. Further, it appears that 
the longer peptides are more active than Afa3 and its 
variants, reminiscent of a similar trend among the cor- 
responding chimeric proteins. Contrary to expectation, 
the data did not provide evidence that free peptides 
possess significantly higher activities than their parent 
molecules. We suspect that much of the variability in 
measured activities could have been due to varying effi- 
ciencies of redissolving the peptides after frozen storage. 
We attempted to correlate the HPLC elution posi- 
tions of the free peptides with two predictable proper- 
ties: hydropathic index (mean hydropathy per residue) 
and length. Although the correlation with hydropathic 
index (Fig. 3a) appeared good, it was imperfect because 
Afa2 elutes before Afa3sB and Afa3swR. This anomaly 
cannot be ascribed to our arbitrary choice of the hydro- 
phobicity scale of Kyte and Doolittle [15]: the hydro- 
phobicity scales of Argos et al., Chothia, Eisenberg, 
Janin, von Heijne and Blomberg, and Wolfenden (re- 
viewed by Eisenberg [17]) all estimate Afa2 as more 
hydrophobic than Afa3sB and Afa3s,. The anomalous 
elution position of Afa2 probably indicates that peptide 
length is a factor in elution behavior. Elution position 
appeared to correlate negatively with the reciprocal of 
peptide length (Fig. 3b) but this correlation of course 
could not predict the different elution positions of Afa3, 
Afa3R, Afa3sB and Afa3s,,,. By trial and error, we 
found a formula combining the variables of hydropathy 
Table III 
Fig. 3. Scatter-chart correlations of observed elution positions of Afa 
peptides (ordinate) with known parameters (abscissa). (a) Correlation 
with adjusted hydropathy. (b) Correlation with the reciprocal of pep- 
tide length (residues-‘). (c) Correlation with the combined parameter, 
(adjusted hydropathy) - (16/peptide l ngth). (The factor of 16 in this 
Titration of recrystallization inhibition activities of free Afa peptides function is empirically derived.) 
Peptide Range of mic* estimates (&ml) 
Afa2 No inhibition” 
Afa3 13-36 
Afa3a 12-39 
Afa3sWR 628 
Afa3s, S-40 
Afa4 4-9 
Afa5 547 
Afa6 3-9 
*mic, minimum inhibitory concentration for complete inhibition of 
recrystallization. 
“The highest concentration tested was 96 &ml. 
a 2 ‘O 
1” 65 
8 
.Y 
60 
s 65 
g 50 
E 
46 
:z 40 
836 
.g 30 
iii 26 
. 
Afa6 
. 
Afa5 
. 
Ala4 
Ala3 
. . 
Afa3R 
Hydropathii index 
- Afa6’ 
Afa6’ 
Afa4’ 
Afa3 
Ala+ 
: 
Af a3 SB 
Af%m Afa2. 
-I 
0.0100 0.0160 0.0200 0.0250 0.0300 0.0350 0.0400 
bciprocal of residue number 
,” 
65- 
w- 
55- 
50 - 
45’ 
40. 
35. Af=?ss 
30. 
n n zfa3SB/A 
AM? 
.= 
Ala3 
AfaQ 
. 
Ala4 
. 
Afat 
. 
Ata 
-I 
0.00 0.10 0.20 0.30 0.40 0.50 0.60 0.70 0.50 0.60 
Combined parameter 
and length into a single variable which correlated well 
with the elution positions of all peptides (Fig. 3~): 
(Hydropathic index) - 
16 
(Peptide length in residues) 
An alternative formula produces a combined variable 
which also has a good correlation to elution position 
(data not shown): 
(Hydropathic index) x 
(Peptide length in residues) 
(Peptide length in residues) + 40 
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4. DISCUSSION 
A series of peptides analogous to the antifreeze pep- 
tides of winter flounder was generated by site-specific 
cleavage of engineered proteins synthesized in E. coli. 
The peptides were identified by HPLC on the basis of 
two criteria. First, each gave a novel peak, the position 
of which varied with the peptide’s composition, in the 
A,,, elution spectrum. Second, each lacked absorbance 
at 280 nm, unlike the material giving rise to other peaks 
in the A2,6 elution spectrum, but as expected for a pep- 
tide lacking aromatic side chains. The identification was 
further supported by amino acid analysis and amino- 
terminal sequencing of one of the peptides. 
All the antifreeze peptides, except that containing 
only two repeats of the 1 l-amino acid unit, showed 
activity as defined by the ability to inhibit the recrystal- 
lization of ice. This supports conclusions drawn previ- 
ously concerning the minimum number of ice-interac- 
tion residues or minimum helix length required for anti- 
freeze activity [ 181. The peptides’ activities were of the 
same order as those of their parent chimeric proteins 
[lo] on a mass basis, and may be lower on a molar basis. 
This accords with the observation that the activity of an 
insect antifreeze was increased by the addition of an 
antibody directed against it [19]. It was suggested that 
increasing the mass of the ice-binding molecule may 
increase its effectiveness at inhibiting ice growth. 
The HPLC protocol used to identify the peptides dif- 
fers from that more commonly used with reverse-phase 
columns by employing a 2: 1 mixture of isopropanol and 
acetonitrile as the organic eluent, rather than just ace- 
tonitrile. In addition, we utilized C4 columns rather than 
the more hydrophobic C8 columns. We had previously 
been unable to identify the longer, more hydrophobic 
peptides when employing the standard protocol. 
The HPLC elution positions of the peptides corre- 
lated with two of their predicted properties: mean hy- 
dropathy (per residue), and length (in residues). We 
obtained functions empirically, combining hydropathy 
and length, that appeared adequate for predicting 
HPLC elution positions. These may be of value in iden- 
tifying longer peptides in the winter flounder and other 
fish producing similarly alanine-rich antifreeze pep- 
tides. Because our data were used to optimize the com- 
bined functions, they do not prove the validity of this 
treatment. However, the treatment is realistic: it is rea- 
sonable to expect molecular adsorption not only to de- 
pend on the mean hydrophobicity of a peptide but also 
to become stronger in longer molecules with more sites 
available for interaction with the substrate. 
Acknowledgements: The authors thank Drs. Arthur DeVries, Mark 
Harpster, Gary Kuroki and Paul Wolber, for critical reviews of the 
manuscript, and Paul Wolber for advice and assistance in running 
HPLC. 
REFERENCES 
111 
121 
131 
[41 
[51 
Fl 
[71 
PI 
PI 
WI 
1111 
WI 
1131 
u41 
u51 
1161 
[I71 
1181 
u 91 
Cheng, CC. and DeVries, A.L. (1991) in: Life Under Extreme 
Conditions (G. di Prisco, ed.) pp. 1-14, Springer-Verlag, NY. 
Feeney, R.E. (1988) Comments Agric. Food Chem. 1, 147-181. 
Davies, P.L. and Hew, CL. (1990) FASEB J. 4, 2460-2468. 
Duman. J. and Horwath, K. (1983) Annu. Rev. Physiol. 45, 
261-270. 
Fourney, R.M., Hew, CL., Joshi, S.B. and Fletcher, G.L. (1984) 
Comp. Biochem. Physiol. B 78, 791-796. 
Hew, CL., Joshi, S.B. and Wang, N.C. (1984) J. Chromatogr. 
296, 213-219. 
Gourlie, B., Lin, Y., Price, J., DeVries, A.L., Powers, D. and 
Huang, R.C.C. (1984) J. Biol. Chem. 259, 1496c-14965. 
Gauthier, S., Wu, Y. and Davies, P.L. (1990) Nucleic Acids Res. 
18, 5303. 
Lin. Y. and Gross, J.K. (1981) Proc. Natl. Acad. Sci. USA 78, 
282552829. 
Mueller, G.M., McKown, R.L., Corotto, L.V., Hague, C. and 
Warren, G.J. (1991) J. Biol. Chem. 266, 7339-7344. 
Knight, C.A., DeVries, A.L. and Oolman, L.D. (1984) Nature 
308, 295-296. 
Knight, CA. and Duman, J.G. (1986) Cryobiology 23,256262. 
Franks, F., Darlington, J., Schenz, T., Mathias, SF., Slade. L. 
and Levine, H. (1987) Nature 325, 146147. 
Gross, E. (1967) Methods Enzymol. 11, 238-255. 
Kyte, J. and Doolittle, R. (1982) J. Mol. Biol. 157, 105-132. 
Knight, C.A., Hallett, J. and DeVries, A.L. (1988) Cryobiology 
25, 55-60. 
Eisenberg, D. (1984) Annu. Rev. Biochem. 53, 595-623. 
Chakrabartty, A., Yang, D.S.C. and Hew, CL. (1989) J. Biol. 
Chem. 264, 11313311316. 
Wu, D.W., Duman, J.G. and Xu, L. (1991) Biochim. Biophys. 
Acta 1076, 416-420. 
120 
